FOXN2 / HTLF antibody
Principal name
FOXN2 / HTLF antibody
Alternative names for FOXN2 / HTLF antibody
Forkhead box protein N2, Human T-cell leukemia virus enhancer factor
Ncbi ID
NP_002149, NP_002149.2, 9606, NM_180974, ABZ92013.1, NM_002158
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E)
Background of FOXN2 / HTLF antibody
Human T-cell leukemia virus enhancer factor (HTLF) may be a forkhead domain binding protein. It may function in the transcriptional regulation of the human T-cell leukemia virus long terminal repeat.Human T-cell leukemia virus enhancer factor (HTLF) may be a forkhead domain binding protein. It may function in the transcriptional regulation of the human T-cell leukemia virus long terminal repeat.
General readings
Rose, J. Phd, et al. Mol. Med. (2010) In press
Li, C., et al. Genomics 13(3):658-664(1992)







Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA314036 | FOXN2 / HTLF antibody |
||||||
| Rabbit polyclonal anti-FOXN2 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP51717PU-N | FOXN2 / HTLF (N-term) antibody |
||||||
![]() |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP309269 | FOXN2 / HTLF |
||||
| Recombinant protein of human forkhead box N2 (FOXN2) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY419494 | FOXN2 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |






